Page last updated: 2024-08-23

azoxymethane and Bifidobacteriales Infections

azoxymethane has been researched along with Bifidobacteriales Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, MJ; Cheon, JH; Kim, HM; Kim, SA; Kim, SK; Kim, SW; Kim, TI; Kim, WH; Lee, SK; Park, JJ; Yang, KM1

Other Studies

1 other study(ies) available for azoxymethane and Bifidobacteriales Infections

ArticleYear
Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:9

    Topics: Acute Disease; Animals; Azoxymethane; Bifidobacteriales Infections; Bifidobacterium; Blotting, Western; Carcinogens; Chronic Disease; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Immunoenzyme Techniques; Inflammation; Intestinal Mucosa; Lipopolysaccharides; Luciferases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2010